Study reveals a new approach to enhancing response to immunotherapy in melanoma

bySanford Burnham Prebys Medical Discovery InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Scientists at

Updated on: December 20,2023

Study reveals a new approach to enhancing response to immunotherapy in melanoma

bySanford Burnham Prebys Medical Discovery InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Scientists at

Updated on:December 20,2023

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on: December 17,2023

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on:December 17,2023

AI in Oncology: Balancing Innovation with Ethical Oversight

Updated on: July 21,2025

AI in Oncology: Balancing Innovation with Ethical Oversight

Updated on:July 21,2025

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi

Updated on: December 19,2023

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi

Updated on:December 19,2023

Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

by Cara MurezBile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.Knowing the signs of these rare cancers may help with earlier detection.Gallbladd

Updated on: December 20,2023

Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

by Cara MurezBile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.Knowing the signs of these rare cancers may help with earlier detection.Gallbladd

Updated on:December 20,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Updated on: December 22,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Updated on:December 22,2023

Sexual side effects of cancer treatment often unaddressed with female patients

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients th

Updated on: December 18,2023

Sexual side effects of cancer treatment often unaddressed with female patients

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients th

Updated on:December 18,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on: December 21,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on:December 21,2023

Why are tall people more likely to get cancer? What we know, don't know and suspect

by Susan Jordan and Karen Tuesley,The ConversationCredit: Andrea Piacquadio from PexelsPeople who are taller are at greater risk of developing cancer. TheWorld Cancer Research Fundre

Updated on: September 07,2024

Why are tall people more likely to get cancer? What we know, don't know and suspect

by Susan Jordan and Karen Tuesley,The ConversationCredit: Andrea Piacquadio from PexelsPeople who are taller are at greater risk of developing cancer. TheWorld Cancer Research Fundre

Updated on:September 07,2024

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on: January 04,2024

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on:January 04,2024

Advances in Understanding the Role of TREM2+ Macrophages in Breast Cancer Lung Metastasis

Updated on: July 10,2024

Advances in Understanding the Role of TREM2+ Macrophages in Breast Cancer Lung Metastasis

Updated on:July 10,2024

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on: December 26,2023

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on:December 26,2023